The BDN Opinion section operates independently and does not set news policies or contribute to reporting or editing articles elsewhere in the newspaper or on bangordailynews.com Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry
Understanding the expected timeline for semaglutide effects helps you frame these questions
They know patients are desperate for innovation, but they still need trusted, transparent protocols for application
When combined with nutrition guidance, regular physical activity, and ongoing follow-up, Contrave may support a structured and personalized approach to medical weight management
Lillys Mounjaro, whose main ingredient is tirzepatide, was approved by the FDA in 2022 to treat diabetes, though it has also been used for weight loss
Silver, K